Privia Health Group (NASDAQ:PRVA) Now Covered by Analysts at KeyCorp

KeyCorp assumed coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report sent to investors on Friday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a $23.00 price target on the stock.

A number of other analysts have also recently weighed in on PRVA. Royal Bank of Canada reiterated an outperform rating and set a $28.00 price target on shares of Privia Health Group in a research report on Wednesday, August 14th. Robert W. Baird increased their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an outperform rating in a research report on Monday, August 26th. Finally, Evercore ISI cut their target price on Privia Health Group from $23.00 to $20.00 and set an outperform rating on the stock in a research note on Tuesday, July 9th. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of Buy and an average price target of $24.73.

Privia Health Group Price Performance

Privia Health Group stock opened at $17.76 on Friday. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $24.35. The company has a fifty day moving average price of $18.87 and a two-hundred day moving average price of $18.32. The company has a market cap of $2.12 billion, a PE ratio of 118.40, a P/E/G ratio of 3.93 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.02). Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The business had revenue of $422.30 million during the quarter, compared to analyst estimates of $411.50 million. During the same period last year, the firm posted $0.06 earnings per share. The company’s quarterly revenue was up 2.2% on a year-over-year basis. Equities research analysts anticipate that Privia Health Group will post 0.16 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 14.20% of the stock is currently owned by company insiders.

Institutional Trading of Privia Health Group

A number of hedge funds have recently bought and sold shares of the company. Canada Pension Plan Investment Board purchased a new position in shares of Privia Health Group in the second quarter worth approximately $26,000. GAMMA Investing LLC boosted its stake in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares during the period. Nisa Investment Advisors LLC grew its position in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after purchasing an additional 930 shares in the last quarter. Signaturefd LLC raised its stake in Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after purchasing an additional 626 shares during the period. Finally, Park Place Capital Corp lifted its holdings in shares of Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after purchasing an additional 1,335 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.